Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update
UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare ...
News-Medical.Net39m
How gut health shapes heart disease risk — and what you can do about it
A new review highlights how gut microbiome imbalances contribute to cardiovascular disease by altering short-chain fatty ...